Perspectiva ética da atribuição de ajudas técnicas/produtos de apoio a doentes idosos com dependência funcional

Mestrado em BioéticaMaster Degree Course in Bioethic

the Portuguese model

info:eu-repo/semantics/publishedVersio

O3-2 evaluation of implementation and impact of a national mass media campaign to promote active lifestyles in Portugal: 'follow the whistle: physical activity is calling you'

info:eu-repo/semantics/publishedVersio

Adverse Events After Pneumococcal Vaccination.

To study the occurrence of adverse events after administration of a capsular polysaccharide vaccine against 23 pneumococcal serotypes in individuals for whom such vaccination is indicated. This was a prospective study, conducted in a general hospital in the city of Sumaré, in which 152 individuals were evaluated after intramuscular vaccination with 0.5 mL of the Pneumo 23 vaccine. The study variable was subject complaint of at least one symptom forming a temporal nexus with the vaccine (appearing within 48 h after its administration). The subjects were evaluated at five to seven days after vaccination. The covariables age, gender and clinical profile were tested using the chi-square test and multiple logistic regression, with the level of significance set at 5%. The age of the population ranged from 5 to 86 years (mean, 61.8 years). For nearly all (99%) of the subjects, the vaccination evaluated was their first dose of the vaccine. Events occurring at the injection site were reported in 36 subjects (23.7%). Of those 36 events, 24 (68%) were mild and had no repercussions for the daily activities of the subjects. Pain at the site of the injection was the most common symptom, being reported by 97.2% of the subjects. Erythema and localized edema were found in 6.3% and 5.1% of the subjects, respectively. Of the subjects evaluated, 12.8% reported general symptoms (malaise, fever, sleepiness and generalized pain). In the bivariate analysis, none of the covariables were found to present a statistically significant correlation with adverse events (p > 0.20). The same held true in the multivariate analysis. Although, the 23-valent pneumococcal vaccine provokes few reactions in the first dose, it is still rarely recommended in the region, even for patients at risk.3351-

“Follow the whistle: physical activity is calling you”: evaluation of implementation and impact of a Portuguese nationwide mass media campaign to promote physical activity

To raise perceived capability (C), opportunity (O) and motivation (M) for physical activity (PA) behaviour (B) among adults, the Portuguese Directorate-General of Health developed a mass media campaign named “Follow the Whistle”, based on behaviour change theory and social marketing principles. Comprehensive formative and process evaluation suggests this media-led campaign used best-practice principles. The campaign adopted a population-wide approach, had clear behavioural goals, and clear multi-strategy implementation. We assessed campaign awareness and initial impact using pre (n = 878, 57% women) and post-campaign (n = 1319, 58% women) independent adult population samples via an online questionnaire, comprising socio-demographic factors, campaign awareness and recall, and psychosocial and behavioural measures linked to the COM-B model. PA was assessed with IPAQ and the Activity Choice Index. The post-campaign recall was typical of levels following national campaigns (24%). Post-campaign measures were higher for key theory-based targets (all p < 0.05), namely self-efficacy, perceived opportunities to be more active and intrinsic motivation. The impact on social norms and self-efficacy was moderated by campaign awareness. Concerning PA, effects were found for vigorous activity (p < 0.01), but not for incidental activity. Overall the campaign impacted key theory-based intermediate outcomes, but did not influence incidental activity, which highlights the need for sustained and repeated campaign efforts.info:eu-repo/semantics/publishedVersio

Physical activity promotion tools in the Portuguese primary health care : an implementation research

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).Background: This paper aims to discuss how physical activity (PA) brief assessment, brief counseling, and self-monitoring tools were designed and implemented in the Portuguese National Health Service (NHS), and to report on their current use by health professionals and citizens. Methods: Three digital tools to facilitate PA promotion in primary health care (PHC) were developed: 1) a PA brief assessment tool was incorporated in the electronic health record platform “SClínico Cuidados de Saúde Primários“; 2) a brief counseling tool was developed in the software “PEM—Prescrição Eletrónica Médica” (electronic medical prescription); and 3) a “Physical Activity Card” was incorporated in an official NHS smartphone app called “MySNS Carteira”. Results: From September 2017 to June 2019, 119,386 Portuguese patients had their PA assessed in PHC. Between December 2017 and June 2019, a total of 7957 patients received brief intervention for PA by a medical doctor. Regarding the app “MySNS Carteira”, 93,320 users activated the “Physical Activity Card”, between February 2018 and December 2018. Conclusions: These tools represent key actions to promote PA among Portuguese citizens using PHC as a priority setting. Further initiatives will follow, including proper assessment of their clinical impact and training programs for health care professionals on PA promotion.info:eu-repo/semantics/publishedVersio

Relato da organização de um serviço dedicado à Covid19: Assegurar a proteção dos profissionais face à exposição ocupacional

info:eu-repo/semantics/publishedVersio

Eventos adversos após vacinação contra o pneumococo

OBJETIVO: Estudar a ocorrência de eventos adversos após aplicação da vacina polissacarídea capsular contra 23 sorotipos do pneumococo em indivíduos com indicação clínica, em Sumaré (SP) (630.000 habitantes). MÉTODOS: Foram investigados prospectivamente 152 indivíduos após vacinação (0,5 mL intramuscular Pneumo23® Aventis Pasteur, Espanha) em um hospital geral. A variável de estudo foi a queixa de pelo menos um sintoma com nexo temporal com a vacina, isto é, nas primeiras 48 h após a aplicação. Os indivíduos foram investigados de cinco a sete dias após a vacinação. As co-variáveis idade, sexo e indicação clínica foram testadas pelo método Qui-quadrado e pelo modelo logístico múltiplo, considerando-se o nível de significância de 5%. RESULTADOS: A idade da população variou de cinco a 86 anos (média de 61,8 anos). A quase totalidade dos indivíduos recebeu a primeira dose na ocasião (99%). Notificou-se a ocorrência de eventos locais em 36 indivíduos (23,7%), entre os quais 68% foram leves, sem repercussão nas atividades diárias. A dor no local da aplicação foi o sintoma mais freqüentemente relatado, por 97,2% dos indivíduos. Eritema e edema local estiveram presentes em 6,3% e 5,1% dos casos, respectivamente. Foram referidos sintomas gerais por 12,8% dos investigados (mal-estar, febre, sonolência, dor no corpo). Nenhuma co-variável relacionou-se estatisticamente com os eventos adversos na análise bivariada (p > 0,20), sendo que a análise múltipla mostrou os mesmos resultados. CONCLUSÃO: A vacina pneumocócica 23-valente é pouco reatogênica na primeira dose, e é ainda pouco indicada na região, mesmo em pacientes de indicação clínica